Breaking News Instant updates and real-time market news.

2019-11-16 04:55:00 MDCO The Medicines Co. $51.92 1.03 (2.02%) 04:55 11/16/19 11/16 04:55 11/16/19 04:55	Roth Capital pharmaceuticals analysts to hold a luncheon Analysts host Dr. John Kastelein, Professor of Medicine at the Department of Vascular Medicine at the Academic Medical Center (AMC) of the University of Amsterdam, who discusses Inclisiran's ORION Trials at a Luncheon Meeting being held in Philadelphia on November 16.	16 Nov
MDCO The Medicines Co. $51.92 1.03 (2.02%) 10/02/19 RILY 10/02/19 NO CHANGE Target $95 RILY Buy The Medicines Co. price target raised to $95 from $74 at B. Riley FBR B. Riley FBR analyst Mayank Mamtani raised his price target for The Medicines Co. (MDCO) to $95 from $74 and added the shares to FBR's Alpha Generator List. The analyst has "heightened conviction" in inclisiran taking a dominant market share in the anti-PCSK9 marketplace, particularly at the expense of Regeneron's (REGN) Praluent. Mamtani's penetration-share scenario analysis suggests worldwide peak sales of $4.1B to $8.0B. The analyst keeps a Buy rating on The Medicines Co. The stock is yet to still reflect last week's "strong" Phase III Orion program execution and evidence generation on safety, efficacy, and durability of effect to reaffirm inclisiran's differentiated clinical profile, Mamtani tells nivestors in a research note. 10/10/19 JEFF 10/10/19 DOWNGRADE Target $50 JEFF Hold The Medicines Co. downgraded to Hold from Buy at Jefferies Jefferies analyst Biren Amin downgraded The Medicines Co. to Hold from Buy with a price target of $50, up from $44. 10/10/19 JEFF 10/10/19 DOWNGRADE Target $50 JEFF Hold Jefferies downgrades The Medicines Co. on 'aggressive' inclisiran estimates Jefferies analyst Biren Amin downgraded The Medicines Co. to Hold from Buy with a price target of $50, up from $44. After We conducting a doctor survey, the analyst thinks inclisiran consensus estimates are "too aggressive" and that The Medicines Co shares appear fully valued. While inclisiran leads in market share for PCSK9i, it is essentially split between inclisiran and Repath, Amin tell investors in a research note after polling 50 cardiologists. Based on the feedback, he lowered his 2026 inclisiran sales estimate to $1.4B from $1.7B, below the current consensus at $2.6B. 10/31/19 JEFF 10/31/19 NO CHANGE Target $50 JEFF Medicines Co. 'going concern' language introduces added risk, says Jefferies Jefferies analyst Biren Amin said new disclosures in The Medicines Company's 10-Q regarding 2022 convertible notes introduces an additional risk as the company's balance sheet is not strong and if holders convert by December the company could require additional near-term funding. The 10-Q stated that if the notes are called and the company can't raise sufficient funds that "there is substantial doubt about the company's ability to continue as a going concern," Amin pointed out. He keeps a Hold rating on Medicines Co. shares.

2019-11-16 04:55:00

MDCO

The Medicines Co.

$51.92: 1.03 (2.02%)

04:55

11/16/19

11/16

04:55

11/16/19

04:55

Roth Capital pharmaceuticals analysts to hold a luncheon

Analysts host Dr. John Kastelein, Professor of Medicine at the Department of Vascular Medicine at the Academic Medical Center (AMC) of the University of Amsterdam, who discusses Inclisiran's ORION Trials at a Luncheon Meeting being held in Philadelphia on November 16.

16
Nov

MDCO The Medicines Co.

$51.92: 1.03 (2.02%)

10/02/19: RILY

10/10/19: JEFF

10/10/19: JEFF

10/31/19: JEFF

TODAY'S FREE FLY STORIES

AZO AutoZone $1,250.39 79.085 (6.75%) 07:33 12/11/19 12/11 07:33 12/11/19 07:33 Recommendations	AutoZone analyst commentary » AutoZone price target… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	12 Dec 18 Dec
DBI Designer Brands $14.18 -2.83 (-16.64%) 07:32 12/11/19 12/11 07:32 12/11/19 07:32 Recommendations	Designer Brands analyst commentary » Designer Brands price… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
BLCM Bellicum Pharmaceuticals $0.80 -0.009 (-1.12%) 07:32 12/11/19 12/11 07:32 12/11/19 07:32 Hot Stocks	Bellicum Pharmaceuticals licenses CaspaCIDe Safety Switch to MD Anderson » Bellicum Pharmaceuticals… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
QRVO Qorvo 07:31 12/11/19 12/11 07:31 12/11/19 07:31 Recommendations	Qorvo analyst commentary » Qorvo price target raised… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
AVGO Broadcom $315.10 0.61 (0.19%) 07:31 12/11/19 12/11 07:31 12/11/19 07:31 Recommendations	Broadcom analyst commentary » Broadcom price target… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	12 Dec

OMCL Omnicell $82.06 2.03 (2.54%) 07:31 12/11/19 12/11 07:31 12/11/19 07:31 Recommendations	Omnicell analyst commentary » Omnicell price target… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
GWW Grainger $323.51 -0.83 (-0.26%) 07:29 12/11/19 12/11 07:29 12/11/19 07:29 Upgrade	Grainger rating change » Grainger upgraded to… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	30 Jan
PLCE Children's Place $70.67 0.68 (0.97%) 07:29 12/11/19 12/11 07:29 12/11/19 07:29 Hot Stocks	Children's Place down 17% to $58.20 after lowering FY19 guidance » The company's Q4… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	11 Dec
BBSI Barrett Business $89.45 1.85 (2.11%) 07:29 12/11/19 12/11 07:29 12/11/19 07:29 Initiation	Barrett Business initiated » Barrett Business… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	13 Dec
MA MasterCard $288.56 -0.48 (-0.17%) 07:28 12/11/19 12/11 07:28 12/11/19 07:28 Recommendations	MasterCard analyst commentary » MasterCard price target… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial

ROK Rockwell Automation $199.78 0.89 (0.45%) 07:28 12/11/19 12/11 07:28 12/11/19 07:28 Upgrade	Rockwell Automation rating change » Rockwell Automation… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
WBT Welbilt $16.32 -0.14 (-0.85%) 07:27 12/11/19 12/11 07:27 12/11/19 07:27 Downgrade	Welbilt rating change » Welbilt downgraded to… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
CCI Crown Castle $134.00 -1.93 (-1.42%) 07:26 12/11/19 12/11 07:26 12/11/19 07:26 Conference/Events	Crown Castle management to meet with MKM Partners » Meeting to be held in New… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	12 Dec
THDDY TV Asahi $0.00 (0.00%) 07:22 12/11/19 12/11 07:22 12/11/19 07:22 Initiation	TV Asahi initiated » TV Asahi initiated with a… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
AEM Agnico Eagle $59.19 -0.11 (-0.19%) 07:21 12/11/19 12/11 07:21 12/11/19 07:21 Upgrade	Agnico Eagle rating change » Agnico Eagle upgraded to… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial

GOLD Barrick Gold 07:21 12/11/19 12/11 07:21 12/11/19 07:21 Upgrade	Barrick Gold rating change » Barrick Gold upgraded to… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
FQVLF First Quantum Minerals $0.00 (0.00%) 07:21 12/11/19 12/11 07:21 12/11/19 07:21 Downgrade	First Quantum Minerals rating change » First Quantum Minerals… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
FJTNY Fuji Media $0.00 (0.00%) 07:21 12/11/19 12/11 07:21 12/11/19 07:21 Initiation	Fuji Media initiated » Fuji Media initiated with… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
EVFM Evofem $6.30 0.03 (0.48%) 07:19 12/11/19 12/11 07:19 12/11/19 07:19 Recommendations	Evofem analyst commentary » Evofem price target… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
PB Prosperity Bancshares $70.40 -0.31 (-0.44%) 07:18 12/11/19 12/11 07:18 12/11/19 07:18 Downgrade	Prosperity Bancshares rating change » Prosperity Bancshares… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial

CASY Casey's General Stores $158.77 -16.56 (-9.45%) 07:17 12/11/19 12/11 07:17 12/11/19 07:17 Recommendations	Casey's General Stores analyst commentary » Casey's General… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
IAG IAMGold $3.40 -0.05 (-1.45%) 07:16 12/11/19 12/11 07:16 12/11/19 07:16 Hot Stocks	IAMGold increases interest in Nelligan project by 24% for C$2.35M » Vanstar Mining Resources… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
AZO AutoZone $1,250.39 79.085 (6.75%) 07:16 12/11/19 12/11 07:16 12/11/19 07:16 Conference/Events	AutoZone management to meet with Morgan Stanley » Group Dinner Meeting with… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	12 Dec 18 Dec
PRQR ProQR Therapeutics $9.09 0.44 (5.09%) 07:13 12/11/19 12/11 07:13 12/11/19 07:13 Hot Stocks	ProQR Therapeutics doses first patient in Phase 1/2 Aurora trial of QR-1123 » ProQR Therapeutics… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
BTAI BioXcel Therapeutics $6.08 -0.07 (-1.14%) 07:12 12/11/19 12/11 07:12 12/11/19 07:12 Hot Stocks	BioXcel Therapeutics to expand BXCL701 study into multiple advanced solid tumors » BioXcel Therapeutics… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial

Events

Earnings calls, analyst events, roadshows and more

PLCE
Today at 08:00

Children's Place - PLCE Conference Calls
Today at 08:30

Consumer Price Index M/M: November 2019 Government Event
Today at 08:30

Consumer Price Index Y/Y: November 2019 Government Event
Today at 08:30

CPI less Food & Energy M/M: November 2019 Government Event
Today at 08:30

CPI less Food & Energy Y/Y: November 2019 Government Event
PLAB
Today at 08:30

Photronics - PLAB Conference Calls
UNFI
Today at 08:30

United Natural Foods - UNFI Conference Calls
AEO
Today at 09:00

American Eagle - AEO Conference Calls
HD
Today at 09:00

The Home Depot, Inc. Firm Sponsored Meetings
KWR
Today at 09:00

Quaker Houghton Firm Sponsored Meetings

New York Stock Exchange Siebert Hall 11 Wall St, New York, NY

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	CRWD X CRWD Crowdstrike Block Trade Managers: Goldman Sachs Priced at: $49.40 2.2M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AUPH X AUPH Aurinia Pharmaceuticals Secondary Managers: Jefferies & SVB Leerink, H.C. Wainwright, Oppenheimer, Bloom Burton Priced at: $15.00 11.1M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial XAIR X XAIR Beyond Air Secondary Managers: SunTrust, National Securities, Roth Capital, Laidlaw Priced at: $3.66 2.325M Shares ABR X ABR Arbor Realty Spot Secondary Managers: JPMorgan, JMP Securities & Raymond James Priced at: $14.14 6.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CFRX X CFRX ContraFect Spot Secondary Managers: Maxim Priced at: $.27 37.15M Shares RHP X RHP Ryman Hospitality Spot Secondary Managers: BofA/Merrill, JPMorgan & Wells Fargo Priced at: $85.60 3M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SCYX X SCYX Scynexis Spot Secondary Managers: H.C. Wainwright Priced at: $.90 38.89M Shares
Tues	XP X XP XP IPO Managers: Goldman Sachs, JPMorgan, Morgan Stanley, XP & Itau BBA, BofA/Merrill, Citi, Credit Suisse, UBS Priced at: $27.00 72.5M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CNST X CNST Constellation Pharmaceuticals Spot Secondary Managers: JPMorgan, Jefferies & Cowen, RBC Capital, SunTrust Priced at: $34.50 6.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MDGL X MDGL Madrigal Pharmaceuticals Spot Secondary Managers: Goldman Sachs Priced at: $107.85 1.2M Shares PMT X PMT PennyMac Mortgage Spot Secondary Managers: Morgan Stanley, Credit Suisse, BofA/Merrill, JPMorgan & Barclays, Nomura Instinet, Piper Jaffray Priced at: $22.10 8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RCKT X RCKT Rocket Pharmaceuticals Spot Secondary Managers: JPMorgan, Cowen & Evercore ISI, LifeSci Priced at: $22.25 3.82M Shares
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	GMRE X GMRE Global Medical REIT Spot Secondary Managers: Stifel, BMO Capital, Baird, KeyBanc & SunTrust $14.13 4.75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial KIDS X KIDS OrthoPediatrics Spot Secondary Managers: Piper Jaffray & Stifel, BTIG, JMP Securities, SunTrust $36.00-36.50 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MRNS X MRNS Marinus Pharmaceuticals Spot Secondary Managers: Oppenheimer & Ladenburg $1.29 PACK X PACK Ranpak Holdings Spot Secondary Managers: Craig-Hallum $5.87
Wed	BILL X BILL Bill.com IPO Managers: Goldman Sachs, BofA/Merrill, Jefferies & KeyBanc, Canaccord, Needham, William Blair $19.00-21.00 8.824M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial EH X EH Ehang IPO Managers: Morgan Stanley, Needham, Tigress Financial, Prime Number $12.50-14.50 3.2M Shares LVGO X LVGO Livongo Health Secondary Managers: Morgan Stanley, Goldman Sachs & JPMorgan $27.43 2.78M Shares MNRL X MNRL Brigham Minerals Secondary Managers: Credit Suisse, Goldman Sachs & RBC Capital $19.70 11M Shares
Thurs	OCFT X OCFT OneConnect IPO Managers: Morgan Stanley, Goldman Sachs, JPMorgan & Ping An of China, BofA/Merrill, HSBC, CLSA, KeyBanc $12.00-14.00 36M Shares SPT X SPT Sprout Social IPO Managers: Goldman Sachs, Morgan Stanley, KeyBanc & William Blair, Canaccord, Stifel $16.00-18.00 8.824M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AQST X AQST Aquestive Therapeutics Secondary Managers: BMO Capital $7.51 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PHR X PHR Phreesia Secondary Managers: JPMorgan, Wells Fargo, William Blair, Allen & Co., Piper Jaffray, Baird, Raymond James $28.72 6M Shares
Fri	No deals

View All Syndicate Announcements »

Roth Capital pharmaceuticals analysts to hold a luncheon

TODAY'S FREE FLY STORIES

Get Full Fly Access